F-5APTORUM GROUP LIMITED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Stated in U.S. Dollars)
1. ORGANIZATIONThe condensed consolidated financial statemen ts include the financial statements of Ap torum Group Limited (the “Company”) and i ts subsidiaries.
The Company and its subsidiaries are hereinafter collectively referred to as the “Group”.
The Company, formerly known as APTUS Holdings Limited and STRIKER ASIA OPPORTUNITIES FUND CORPORATION, is a company
incorporated on September 13, 20 10 under the laws of the Cayman Islands with limited liability.
The Company researches and develops life science and biopharmaceu tical products within its wholly-owned subsidiary, Aptorum The rapeutics
Limited, formerly known as APTUS Therapeuti cs Limited (“Aptorum Therapeutics”) and its indirect subsidiary companies (collectiv ely, “Aptorum
Therapeutics Group”).
2. LIQUIDITYThe Company reported a net loss of $6,988,314 and net operating cash outflow of $7,025,945 for the six months ended June 30, 20 20. In addition,
the Company had an accumulated deficit of $43,760,545 as of June 30, 2020. The Company’s operating results for future periods a re subject to
numerous uncertainties and it is uncertain if the Company will be  able to reduce or eliminate its net losses for the foreseeabl e future. If management
is not able to generate significant revenues from its product candi dates currently in development, the Company may not be able to achieve
profitability.

### Language ###
English

### Assessment ###
We can ask about the company's net loss for a specific time period, which is a clear factual piece of information from the text.

### Query ###
What was Aptorum Group Limited's net loss for the first half of 2020?
What was Aptorum Group Limited's net loss for the first half of 2020?